Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Jul;37(1):327–335. doi: 10.1128/iai.37.1.327-335.1982

Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae.

P Domenico, W G Johanson Jr, D C Straus
PMCID: PMC347530  PMID: 7049951

Abstract

Transtracheal instillation of clinical isolate Klebsiella pneumoniae serotype 1 (KP1) into the lungs of rats resulted in the production of a characteristic, chronic lobar pneumonia. To further examine this phenomenon, two variants of this organism were employed in this experimental model. These variants differed markedly in capsule size, colony morphology, and in virulence, as determined by mouse lethality tests. The ability of these strains to establish a lobar pneumonia in rats correlated with the virulence of the respective organisms as monitored by intraperitoneal injection in mice. The 50% lethal doses in mice were 4.9 x 10(1) colony-forming units (CFU) for the more virulent KP1 strain (KP1-O) and 1.42 x 10(5) CFU for the less virulent variant (KP1-T). In the rat lung model, marked lung pathology was evident by day 6 with a KP1-O inoculum of 5 x 10(2) CFU, whereas KP1-T caused little or no lung pathology when delivered transtracheally at a concentration of 7 x 10(6) CFU. Two relatively nonvirulent variants of K. pneumoniae serotype 2 were also used in this rat lung model and were found not to produce a lobar pneumonia even when delivered in large doses. These results indicate that a chronic lobar pneumonia can be established in a rat model if the appropriate organism is employed and the virulence of K. pneumoniae injected intraperitoneally into mice is an excellent indicator of an organism's potential to cause lobar pneumonia in rats.

Full text

PDF
327

Images in this article

330Image
on p.330
330Image
on p.330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAER H., EHRENWORTH L. The pathogenicity of Klebsiella pneumoniae for mice: the relationship to the quantity and rate of production of type-specific capsular polysaccharide. J Bacteriol. 1956 Nov;72(5):713–717. doi: 10.1128/jb.72.5.713-717.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BATSHON B. A., BAER H., SHAFFER M. F. Immunologic paralysis produced in mice by Klebsiella pneumoniae type 2 polysaccharide. J Immunol. 1963 Jan;90:121–126. [PubMed] [Google Scholar]
  3. Berendt R. F., Knutsen G. L., Powanda M. C. Nonhuman primate model for the study of respiratory Klebsiella pneumoniae infection. Infect Immun. 1978 Oct;22(1):275–281. doi: 10.1128/iai.22.1.275-281.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berendt R. F., Long G. G., Abeles F. B., Canonico P. G., Elwell M. R., Powanda M. C. Pathogenesis of respiratory Klebsiella pneumoniae infection in rats: bacteriological and histological findings and metabolic alterations. Infect Immun. 1977 Feb;15(2):586–593. doi: 10.1128/iai.15.2.586-593.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Canonico P. G., Powanda M. C., Cockerell G. L., Moe J. B. Relationship of serum beta-glucuronidase and lysozyme to pathogenesis of tularemia in immune and nonimmune rats. Infect Immun. 1975 Jul;12(1):42–47. doi: 10.1128/iai.12.1.42-47.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DUGUID J. P. The demonstration of bacterial capsules and slime. J Pathol Bacteriol. 1951 Oct;63(4):673–685. doi: 10.1002/path.1700630413. [DOI] [PubMed] [Google Scholar]
  7. Durham D. L., Mattingly S. J., Doran T. I., Milligan T. W., Straus D. C. Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model. Infect Immun. 1981 Nov;34(2):448–454. doi: 10.1128/iai.34.2.448-454.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. EDWARDS P. R., FIFE M. A. Capsule types of Klebsiella. J Infect Dis. 1952 Jul-Aug;91(1):92–104. doi: 10.1093/infdis/91.1.92. [DOI] [PubMed] [Google Scholar]
  9. EDWARDS P. R., FIFE M. A. Studies on the Klebsiella-Aerobacter group of bacteria. J Bacteriol. 1955 Oct;70(4):382–390. doi: 10.1128/jb.70.4.382-390.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. ERASMUS L. D. Friedländer bacillus infection of the lung; with special reference to classification and pathogenesis. Q J Med. 1956 Oct;25(100):507–521. [PubMed] [Google Scholar]
  11. GILL R. J. Treatment of Friedlander's pneumonia. Am J Med Sci. 1951 Jan;221(1):5–9. doi: 10.1097/00000441-195101000-00002. [DOI] [PubMed] [Google Scholar]
  12. Graybill J. R., Marshall L. W., Charache P., Wallace C. K., Melvin V. B. Nosocomial pneumonia. A continuing major problem. Am Rev Respir Dis. 1973 Nov;108(5):1130–1140. doi: 10.1164/arrd.1973.108.5.1130. [DOI] [PubMed] [Google Scholar]
  13. Hoffman N. R., Preston F. S., Jr Friedlander's pneumonia. A report of 11 cases and appraisal of antibiotic therapy. Dis Chest. 1968 Apr;53(4):481–486. doi: 10.1378/chest.53.4.481. [DOI] [PubMed] [Google Scholar]
  14. Hoffman T. A., Edwards E. A. Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis. J Infect Dis. 1972 Dec;126(6):636–644. doi: 10.1093/infdis/126.6.636. [DOI] [PubMed] [Google Scholar]
  15. Lorian V., Topf B. Microbiology of nosocomial infections. Arch Intern Med. 1972 Jul;130(1):104–110. [PubMed] [Google Scholar]
  16. MacLEOD C. M., KRAUS M. R. Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro. J Exp Med. 1950 Jul 1;92(1):1–9. doi: 10.1084/jem.92.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Martin W. J., Yu P. K., Washington J. A., 2nd Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc. 1971 Dec;46(12):785–793. [PubMed] [Google Scholar]
  18. Osserman E. F., Lawlor D. P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med. 1966 Nov 1;124(5):921–952. doi: 10.1084/jem.124.5.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pierce A. K., Sanford J. P. Aerobic gram-negative bacillary pneumonias. Am Rev Respir Dis. 1974 Nov;110(5):647–658. doi: 10.1164/arrd.1974.110.5.647. [DOI] [PubMed] [Google Scholar]
  20. Pollack M. Significance of circulating capsular antigen in Klebsiella infections. Infect Immun. 1976 Jun;13(6):1543–1548. doi: 10.1128/iai.13.6.1543-1548.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yokochi T., Nakashima I., Kato N. Effect of capsular polysaccharide of Klebsiella pneumoniae on the differentiation and functional capacity of macrophages cultured in vitro. Microbiol Immunol. 1977 Oct 20;21(10):601–610. doi: 10.1111/j.1348-0421.1977.tb00328.x. [DOI] [PubMed] [Google Scholar]
  22. Yokochi T., Nakashima I., Kato N. Further studies on generation of macrophages in in vitro cultures of mouse spleen cells and its inhibition by the capsular polysaccharide of Klebsiella pneumoniae. Microbiol Immunol. 1979;23(6):487–499. doi: 10.1111/j.1348-0421.1979.tb00488.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES